13-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]-N-[4-[3-[[(5R)-3-[2-[(4-fluorophenyl)methyl-[(2S)-1,1,1-trifluoropropan-2-yl]amino]-2-oxoethyl]-2,4-dioxospiro[1,3-oxazolidine-5,1'-2,3-dihydroindene]-5'-yl]amino]-3-oxopropyl]phenyl]tridecanamide

C58H62F4N6O10 — CID 163935850

IUPAC13-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]-N-[4-[3-[[(5R)-3-[2-[(4-fluorophenyl)methyl-[(2S)-1,1,1-trifluoropropan-2-yl]amino]-2-oxoethyl]-2,4-dioxospiro[1,3-oxazolidine-5,1'-2,3-dihydroindene]-5'-yl]amino]-3-oxopropyl]phenyl]tridecanamide
SMILESC[C@H](N(Cc1ccc(F)cc1)C(=O)CN1C(=O)O[C@@]2(CCc3cc(NC(=O)CCc4ccc(NC(=O)CCCCCCCCCCCCc5ccc6c(c5)C(=O)N(C5CCC(=O)NC5=O)C6=O)cc4)ccc32)C1=O)C(F)(F)F
InChIInChI=1S/C58H62F4N6O10/c1-36(58(60,61)62)66(34-39-14-20-41(59)21-15-39)51(72)35-67-55(76)57(78-56(67)77)31-30-40-33-43(24-26-46(40)57)64-49(70)28-19-37-16-22-42(23-17-37)63-48(69)13-11-9-7-5-3-2-4-6-8-10-12-38-18-25-44-45(32-38)54(75)68(53(44)74)47-27-29-50(71)65-52(47)73/h14-18,20-26,32-33,36,47H,2-13,19,27-31,34-35H2,1H3,(H,63,69)(H,64,70)(H,65,71,73)/t36-,47?,57+/m0/s1
InChIKeyRMSSINSJTCENJP-CJOKAGBPSA-N
MW1079.16 g/mol
LogP9.37
Rot. Bonds24

About 13-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]-N-[4-[3-[[(5R)-3-[2-[(4-fluorophenyl)methyl-[(2S)-1,1,1-trifluoropropan-2-yl]amino]-2-oxoethyl]-2,4-dioxospiro[1,3-oxazolidine-5,1'-2,3-dihydroindene]-5'-yl]amino]-3-oxopropyl]phenyl]tridecanamide

13-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]-N-[4-[3-[[(5R)-3-[2-[(4-fluorophenyl)methyl-[(2S)-1,1,1-trifluoropropan-2-yl]amino]-2-oxoethyl]-2,4-dioxospiro[1,3-oxazolidine-5,1'-2,3-dihydroindene]-5'-yl]amino]-3-oxopropyl]phenyl]tridecanamide (PubChem CID 163935850) has the molecular formula C58H62F4N6O10 and a molecular weight of 1079.16 g/mol. Its IUPAC name is 13-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]-N-[4-[3-[[(5R)-3-[2-[(4-fluorophenyl)methyl-[(2S)-1,1,1-trifluoropropan-2-yl]amino]-2-oxoethyl]-2,4-dioxospiro[1,3-oxazolidine-5,1'-2,3-dihydroindene]-5'-yl]amino]-3-oxopropyl]phenyl]tridecanamide.

Molecular Properties

Compound Name13-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]-N-[4-[3-[[(5R)-3-[2-[(4-fluorophenyl)methyl-[(2S)-1,1,1-trifluoropropan-2-yl]amino]-2-oxoethyl]-2,4-dioxospiro[1,3-oxazolidine-5,1'-2,3-dihydroindene]-5'-yl]amino]-3-oxopropyl]phenyl]tridecanamide
PubChem CID163935850
Molecular FormulaC58H62F4N6O10
Molecular Weight1079.16 g/mol
Exact Mass1078.45
IUPAC Name13-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]-N-[4-[3-[[(5R)-3-[2-[(4-fluorophenyl)methyl-[(2S)-1,1,1-trifluoropropan-2-yl]amino]-2-oxoethyl]-2,4-dioxospiro[1,3-oxazolidine-5,1'-2,3-dihydroindene]-5'-yl]amino]-3-oxopropyl]phenyl]tridecanamide
SMILESC[C@H](N(Cc1ccc(F)cc1)C(=O)CN1C(=O)O[C@@]2(CCc3cc(NC(=O)CCc4ccc(NC(=O)CCCCCCCCCCCCc5ccc6c(c5)C(=O)N(C5CCC(=O)NC5=O)C6=O)cc4)ccc32)C1=O)C(F)(F)F
InChIInChI=1S/C58H62F4N6O10/c1-36(58(60,61)62)66(34-39-14-20-41(59)21-15-39)51(72)35-67-55(76)57(78-56(67)77)31-30-40-33-43(24-26-46(40)57)64-49(70)28-19-37-16-22-42(23-17-37)63-48(69)13-11-9-7-5-3-2-4-6-8-10-12-38-18-25-44-45(32-38)54(75)68(53(44)74)47-27-29-50(71)65-52(47)73/h14-18,20-26,32-33,36,47H,2-13,19,27-31,34-35H2,1H3,(H,63,69)(H,64,70)(H,65,71,73)/t36-,47?,57+/m0/s1
InChIKeyRMSSINSJTCENJP-CJOKAGBPSA-N
XLogP9.37
TPSA208.67 Ų
H-Bond Donors3
H-Bond Acceptors10
Rotatable Bonds24
Heavy Atoms78
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 5001079.16
LogP ≤ 59.37
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1010

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze 13-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]-N-[4-[3-[[(5R)-3-[2-[(4-fluorophenyl)methyl-[(2S)-1,1,1-trifluoropropan-2-yl]amino]-2-oxoethyl]-2,4-dioxospiro[1,3-oxazolidine-5,1'-2,3-dihydroindene]-5'-yl]amino]-3-oxopropyl]phenyl]tridecanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 13-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]-N-[4-[3-[[(5R)-3-[2-[(4-fluorophenyl)methyl-[(2S)-1,1,1-trifluoropropan-2-yl]amino]-2-oxoethyl]-2,4-dioxospiro[1,3-oxazolidine-5,1'-2,3-dihydroindene]-5'-yl]amino]-3-oxopropyl]phenyl]tridecanamide?
The IUPAC name of 13-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]-N-[4-[3-[[(5R)-3-[2-[(4-fluorophenyl)methyl-[(2S)-1,1,1-trifluoropropan-2-yl]amino]-2-oxoethyl]-2,4-dioxospiro[1,3-oxazolidine-5,1'-2,3-dihydroindene]-5'-yl]amino]-3-oxopropyl]phenyl]tridecanamide (CID 163935850) is 13-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]-N-[4-[3-[[(5R)-3-[2-[(4-fluorophenyl)methyl-[(2S)-1,1,1-trifluoropropan-2-yl]amino]-2-oxoethyl]-2,4-dioxospiro[1,3-oxazolidine-5,1'-2,3-dihydroindene]-5'-yl]amino]-3-oxopropyl]phenyl]tridecanamide.
What is the SMILES notation for 13-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]-N-[4-[3-[[(5R)-3-[2-[(4-fluorophenyl)methyl-[(2S)-1,1,1-trifluoropropan-2-yl]amino]-2-oxoethyl]-2,4-dioxospiro[1,3-oxazolidine-5,1'-2,3-dihydroindene]-5'-yl]amino]-3-oxopropyl]phenyl]tridecanamide?
The canonical SMILES for 13-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]-N-[4-[3-[[(5R)-3-[2-[(4-fluorophenyl)methyl-[(2S)-1,1,1-trifluoropropan-2-yl]amino]-2-oxoethyl]-2,4-dioxospiro[1,3-oxazolidine-5,1'-2,3-dihydroindene]-5'-yl]amino]-3-oxopropyl]phenyl]tridecanamide is C[C@H](N(Cc1ccc(F)cc1)C(=O)CN1C(=O)O[C@@]2(CCc3cc(NC(=O)CCc4ccc(NC(=O)CCCCCCCCCCCCc5ccc6c(c5)C(=O)N(C5CCC(=O)NC5=O)C6=O)cc4)ccc32)C1=O)C(F)(F)F.
What is the InChIKey of 13-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]-N-[4-[3-[[(5R)-3-[2-[(4-fluorophenyl)methyl-[(2S)-1,1,1-trifluoropropan-2-yl]amino]-2-oxoethyl]-2,4-dioxospiro[1,3-oxazolidine-5,1'-2,3-dihydroindene]-5'-yl]amino]-3-oxopropyl]phenyl]tridecanamide?
The InChIKey is RMSSINSJTCENJP-CJOKAGBPSA-N. The full InChI is InChI=1S/C58H62F4N6O10/c1-36(58(60,61)62)66(34-39-14-20-41(59)21-15-39)51(72)35-67-55(76)57(78-56(67)77)31-30-40-33-43(24-26-46(40)57)64-49(70)28-19-37-16-22-42(23-17-37)63-48(69)13-11-9-7-5-3-2-4-6-8-10-12-38-18-25-44-45(32-38)54(75)68(53(44)74)47-27-29-50(71)65-52(47)73/h14-18,20-26,32-33,36,47H,2-13,19,27-31,34-35H2,1H3,(H,63,69)(H,64,70)(H,65,71,73)/t36-,47?,57+/m0/s1.
What are the key properties of 13-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]-N-[4-[3-[[(5R)-3-[2-[(4-fluorophenyl)methyl-[(2S)-1,1,1-trifluoropropan-2-yl]amino]-2-oxoethyl]-2,4-dioxospiro[1,3-oxazolidine-5,1'-2,3-dihydroindene]-5'-yl]amino]-3-oxopropyl]phenyl]tridecanamide?
13-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]-N-[4-[3-[[(5R)-3-[2-[(4-fluorophenyl)methyl-[(2S)-1,1,1-trifluoropropan-2-yl]amino]-2-oxoethyl]-2,4-dioxospiro[1,3-oxazolidine-5,1'-2,3-dihydroindene]-5'-yl]amino]-3-oxopropyl]phenyl]tridecanamide has a molecular weight of 1079.16 g/mol, XLogP of 9.37, 24 rotatable bonds, 3 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for 13-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]-N-[4-[3-[[(5R)-3-[2-[(4-fluorophenyl)methyl-[(2S)-1,1,1-trifluoropropan-2-yl]amino]-2-oxoethyl]-2,4-dioxospiro[1,3-oxazolidine-5,1'-2,3-dihydroindene]-5'-yl]amino]-3-oxopropyl]phenyl]tridecanamide is sourced from PubChem (CID 163935850), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).